Spark Investment Management LLC Amicus Therapeutics, Inc. Transaction History

Spark Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$6.63 - $11.16 $5.41 Million - $9.11 Million	-816,500 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$7.48 - $10.75 $2.85 Million - $4.1 Million	-381,400 Reduced 31.84%	816,500 $7.95 Million
Q3 2019 Nov 12, 2019	SELL	$8.02 - $13.25 $2.75 Million - $4.55 Million	-343,500 Reduced 22.28%	1,197,900 $9.61 Million
Q2 2019 Aug 12, 2019	SELL	$10.96 - $14.4 $712,400 - $936,000	-65,000 Reduced 4.05%	1,541,400 $19.2 Million
Q1 2019 May 07, 2019	BUY	$10.04 - $13.92 $8.26 Million - $11.5 Million	822,700 Added 104.98%	1,606,400 $21.8 Million
Q4 2018 Feb 12, 2019	BUY	$8.38 - $13.44 $5.52 Million - $8.86 Million	659,300 Added 529.98%	783,700 $7.51 Million
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $1.44 Million - $2.06 Million	124,400 New	124,400 $1.5 Million
Q2 2018 Aug 08, 2018	SELL	$13.13 - $17.09 $3.7 Million - $4.81 Million	-281,700 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$13.76 - $17.12 $148,608 - $184,896	10,800 Added 3.99%	281,700 $4.24 Million
Q4 2017 Feb 12, 2018	BUY	$12.51 - $16.24 $3.39 Million - $4.4 Million	270,900	270,900 $3.9 Million

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.66B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.